Horizon Therapeutics
(NASDAQ:HZNP)
$78.21
-0.07[-0.09%]
Last update: 1:57PM (Delayed 15-Minutes)
Get Real Time Here
Day Range77.92 - 79.4652 Wk Range57.84 - 117.49Open / Close78.22 / -Float / Outstanding224.7M / 226.6M
Vol / Avg.777.6K / 2.6MMkt Cap17.7BP/E32.2150d Avg. Price67.81
Div / Yield-Payout Ratio-Total Float224.7MEPS0.59

Horizon Therapeutics Stock (NASDAQ:HZNP), Quotes and News Summary

Horizon Therapeutics Stock (NASDAQ: HZNP) stock price, news, charts, stock research, profile.

Loading...
Day Range77.92 - 79.4652 Wk Range57.84 - 117.49Open / Close78.22 / -Float / Outstanding224.7M / 226.6M
Vol / Avg.777.6K / 2.6MMkt Cap17.7BP/E32.2150d Avg. Price67.81
Div / Yield-Payout Ratio-Total Float224.7MEPS0.59
Seeking Alpha - Oct 27, 2022, 5:51AM
Seeking Alpha - Sep 9, 2022, 8:09AM
Seeking Alpha - Aug 29, 2022, 5:42AM
Seeking Alpha - Aug 2, 2022, 12:22PM
Seeking Alpha - Aug 2, 2022, 10:48AM
Sector: Health Care.Industry: Biotechnology
Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company has two reportable segments: orphan and inflammation. Orphan segment consists of medicines such as TEPEZZA, KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, UPLIZNA, BUPHENYL, and QUINSAIR. Inflammation segment consists of PENNSAID 2%, DUEXIS, RAYOS, and VIMOVO. It generates the vast majority of its revenue from the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS1.0101.250 0.2400
REV888.320M925.359M37.039M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Horizon Therapeutics (HZNP) stock?

A

You can purchase shares of Horizon Therapeutics (NASDAQ: HZNP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Horizon Therapeutics's (HZNP) competitors?

Q

What is the target price for Horizon Therapeutics (HZNP) stock?

A

The latest price target for Horizon Therapeutics (NASDAQ: HZNP) was reported by SVB Leerink on Thursday, November 3, 2022. The analyst firm set a price target for 88.00 expecting HZNP to rise to within 12 months (a possible 12.52% upside). 16 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Horizon Therapeutics (HZNP)?

A

The stock price for Horizon Therapeutics (NASDAQ: HZNP) is $78.21 last updated Today at November 28, 2022, 6:57 PM UTC.

Q

Does Horizon Therapeutics (HZNP) pay a dividend?

A

There are no upcoming dividends for Horizon Therapeutics.

Q

When is Horizon Therapeutics (NASDAQ:HZNP) reporting earnings?

A

Horizon Therapeutics’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Horizon Therapeutics (HZNP) going to split?

A

There is no upcoming split for Horizon Therapeutics.

Q

What sector and industry does Horizon Therapeutics (HZNP) operate in?

A

Horizon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.